AlgoDx is the winner of the rising star category of Swecare Export Awards.
The jury’s motivation
“This year’s winner is an exciting company that developed a method for managing sepsis. Through a platform that uses artificial intelligence to advance diagnosis, you can both save lives and reduce healthcare costs. Using disruptive technology and evidence-based software, they have proven that one of the deadliest syndromes of our time can be predicted with greater certainty than current diagnostic methods. The company has an extremely scalable business model and a robust internationalization strategy, where, among other things, strategic collaborations have been developed with global record system suppliers and actors in the US healthcare system. The jury judges that AlgoDx has great potential for international success.”
Read more: The winner of Swecare Export Award 2023
The nominated companies in this category were AlgoDx, Care to Translate, EMPE Diagnostics, ImagineCare, iZafe Group, Scandinavian Chemotech and Tada Group
Photo of David Becedas, CEO, AlgoDx: Swecare